Avenda Health
Santa Monica, US · Founded 2017 · 1 known investors
Avenda Health develops Unfold AI, an AI-based platform that maps the location and extent of prostate cancer to help physicians select treatment options and plan focal therapy margins. It is used by doctors and patients to guide prostate cancer treatment decisions while preserving quality of life.
Founders & leadership
SN
Shyam Natarajan, Ph.D.Executive Officer, Director
LM
Leonard Marks, M.D.Executive Officer, Director
MK
Michael KleinDirector
BN
Brittany N. Pusey, Ph.DExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.5MraisedJan 2024 · 24 investors · Other Health CareRule 506(b)
▶$3.5MraisedJan 2024 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronald D. Sugar, Ph.D.Director
- Michael KleinDirector
- Leonard S. Marks, M.D.Director
- Shyam Natarajan, Ph.D.Executive Officer, Director
- Brittany N. Pusey, Ph.D.Executive Officer
- Offering amount
- $7M
- Amount sold
- $3.5M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedFeb 2022 · 49 investors · Other Health CareRule 506(b)
▶$6.4MraisedFeb 2022 · 49 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shyam Natarajan, Ph.D.Executive Officer, Director
- Michael KleinDirector
- Brittany N. Pusey, Ph.D.Executive Officer
- Leonard S. Marks, M.D.Director
- Ronald D. Sugar, Ph.D.Director
- Offering amount
- $16.6M
- Amount sold
- $6.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.1MraisedJul 2019 · 20 investors · Other Health CareRule 506(b)
▶$5.1MraisedJul 2019 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shyam Natarajan, Ph.D.Executive Officer, Director
- Leonard Marks, M.D.Executive Officer, Director
- Michael KleinDirector
- Brittany N. Pusey, Ph.DExecutive Officer
- Offering amount
- $13.6M
- Amount sold
- $5.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.3MraisedApr 2018 · 18 investors · Other Health CareRule 506(b)
▶$3.3MraisedApr 2018 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Leonard Marks, M.D.Executive Officer, Director
- Shyam Natarajan, Ph.D.Executive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.